Latest news
Loading news…
BioVaxys
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Etobicoke, Ontario, Canada Founded 2018 1-10 employees For Profit
BioVaxys is a clinical stage biotechnology company developing immunotherapeutic cancer vaccines targeting melanoma.
BioVaxys on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Total Funding
$15.15M
Funding Rounds
18
Last Funding
Acquisitions
2
Monthly Visits
Contacts
1
Ticker
BIOV
CNSX - Canadian National Stock Exchange
Patents
0
7 trademarks
About BioVaxys
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- BIOV
- Exchange
- CNSX - Canadian National Stock Exchange
- IPO date
- Nov 21, 2018
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 1
- Patents granted
- 0
- Trademarks
- 7
- IT spend
- $179.31K
Company Info
- Founded
- 2018
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 3
- News articles
- 125
- HQ
- Etobicoke, Ontario, Canada
- Region
- Great Lakes
- Exit date
- Nov 21, 2018
Signals & Scores
- Heat score
- Medium
- Growth score
- Low
- Trend (7d)
- 0.7
- Trend (30d)
- 1.4
- Trend (90d)
- 0
- Last leadership hire
- Oct 8, 2025
BioVaxys Funding Rounds
18 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–5 of 18Show
Page 1 / 4
BioVaxys Acquisitions
2 results
| Acquiree Name | Acquirer Name | Acquiree Industries | Acquiree Hq Country | ||
|---|---|---|---|---|---|
| Horizon Technology Finance | — | 2025-05-29 | BioVaxys | Financial ServicesFinTechManagement ConsultingVenture Capital | United States |
| TAETSoftware | $1.38M | 2023-03-16 | BioVaxys | — | Canada |
1–2 of 2Show
Page 1 / 1
1
professional contacts at BioVaxys
Contact execs at BioVaxys →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to BioVaxys
Loading news…
FAQs about BioVaxys
People who checked this page also checked these
Sectors BioVaxys invests & acquires in
Browse the full Acquirezy directory.